Brief: 1nkemia licences results of food supplements project to Myogem

1nkemia IUCT SA

05/01/2017 06:58

Jan 5 (Reuters) - 1nkemia IUCT Group S.A.  IKM.MC : 
    * Said on Wednesday that it has agreed to license 
discoveries of its food supplements project 'MYO-DM1' to its 
unit Myogem Health Company S.L. after positive results 
    * With this license it is expected that Myogem will soon put 
on the market a product focused on improving the health of 
people affected by myotonic dystrophy type 1 (DM1), based on 
licensed discoveries 
 
     
 Source text: http://bit.ly/2j6VYUz 
     
 Further company coverage:  IKM.MC   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))